7 Things AbbVie's Top Executives Just Said That You'll Want to Know
It's a good time to be AbbVie (NYSE: ABBV). And with the biotech's share price up more than 50% year to date, it's a good time to be an AbbVie shareholder. The company reported a strong third-quarter performance a couple of weeks ago. AbbVie also increased its dividend for the 45th year in a row (including the years it was part of Abbott Labs (NYSE: ABT)).
But can the good times continue to roll? AbbVie's top executives indirectly answered that question in different ways at the Credit Suisse healthcare conference in Arizona on Wednesday. Here are seven things management said that you'll want to know.
Image source: Getty Images.
Source: Fool.com
AbbVie Inc. Stock
€159.56
-0.850%
The stock is an absolute favorite of our community with 27 Buy predictions and no Sell predictions.
As a result the target price of 175 € shows a slightly positive potential of 9.68% compared to the current price of 159.56 € for AbbVie Inc..
